This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gajra, A. Articles by Graziano, S. L. Search for Related Content PubMed PubMed Citation Articles by Gajra, A. Articles by Graziano, S. L.

Effect of Number of Lymph Nodes Sampled on Outcome in Patients With Stage I Non–Small-Cell Lung Cancer

From the Veterans Affairs Medical Center; and the State University of New York Upstate Medical University, Syracuse, NY.

Address reprint requests to Ajeet Gajra, MD, 800 Irving Ave (111H), Syracuse, NY 13210; email: ajeet.gajra{at}med.va.gov.

Purpose: We postulate that surgical sampling and pathologic evaluation of lymph nodes of surgical specimens from patients with stage I non–small-cell lung cancer (NSCLC) can have an effect on the time to recurrence and survival of these patients.

Patients and Methods: We analyzed data on 442 patients with stage I NSCLC who were treated with surgical resection and some form of lymph node sampling. Associations between total lymph nodes sampled and disease-free survival (DFS) and overall survival (OS) were investigated. The effect of total lymph node stations sampled and the surgical techniques (random lymph node sampling, systematic sampling [SS], or complete mediastinal lymph node dissection [MLND]) on DFS and OS was also studied. Complete MLND and SS were defined as dissection or sampling of levels 4, 7, and 10 for right-sided lesions and levels 5 or 6 and 7 for left-sided lesions.

Results: Patients were divided into quartiles on the basis of total number of lymph nodes sampled. Improved DFS and OS were associated with greater number of lymph nodes sampled. SS and MLND were associated with improved survival compared with random lymph node sampling. The total number of lymph nodes sampled maintained strong significance in the multivariate analysis.

Conclusion: These results indicate that examining a greater number of lymph nodes in patients with stage I NSCLC treated with resection increases the likelihood of proper staging and affects patient outcome. Such information is important not only for therapy and prognosis of individuals but also for identifying those who may benefit from adjuvant therapy.

This article has been cited by other articles:

				W. Zhong, X. Yang, J. Bai, J. Yang, C. Manegold, and Y. Wu Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 187 - 195. [Abstract] [Full Text] [PDF]

				N. Wu, C. Lv, S. Yan, H. Duan, Q. Zheng, J. Wang, H. Xiong, and Y. Yang Systemic mediastinal lymph node dissection of right lung cancer: surgical quality control and analysis of mediastinal lymph node metastatic patterns Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 240 - 243. [Abstract] [Full Text] [PDF]

				N. K. Veeramachaneni, R. J. Battafarano, B. F. Meyers, J. B. Zoole, and G. A. Patterson Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 466 - 469. [Abstract] [Full Text] [PDF]

				J. E. Gervasoni Jr., S. Sbayi, and B. Cady Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data. Ann. Surg. Oncol., September 1, 2007; 14(9): 2443 - 2462. [Abstract] [Full Text] [PDF]

				B. A. Whitson, S. S. Groth, and M. A. Maddaus Surgical Assessment and Intraoperative Management of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 1059 - 1065. [Abstract] [Full Text] [PDF]

				G. Massard, X. Ducrocq, E. A. Kochetkova, V. A. Porhanov, and M. Riquet Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 164 - 167. [Abstract] [Full Text] [PDF]

				M. Okada, T. Sakamoto, T. Yuki, T. Mimura, K. Miyoshi, and N. Tsubota Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non-Small Cell Lung Cancer. Ann. Thorac. Surg., March 1, 2006; 81(3): 1028 - 1032. [Abstract] [Full Text] [PDF]

				A. C. Berger, E. R. Sigurdson, T. LeVoyer, A. Hanlon, R. J. Mayer, J. S. Macdonald, P. J. Catalano, and D. G. Haller Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph Nodes J. Clin. Oncol., December 1, 2005; 23(34): 8706 - 8712. [Abstract] [Full Text] [PDF]

				F. Barlesi, L. Boyer, C. Doddoli, S. Antoniotti, P. Thomas, and P. Auquier The Place of Patient Satisfaction in Quality Assessment of Lung Cancer Thoracic Surgery Chest, November 1, 2005; 128(5): 3475 - 3481. [Abstract] [Full Text] [PDF]

				Bronchogenic Carcinoma Cooperative Group of the Sp Survival of 2,991 Patients With Surgical Lung Cancer: The Denominator Effect in Survival Chest, October 1, 2005; 128(4): 2274 - 2281. [Abstract] [Full Text] [PDF]

				M. S. Ludwig, M. Goodman, D. L. Miller, and P. A. S. Johnstone Postoperative Survival and the Number of Lymph Nodes Sampled During Resection of Node-Negative Non-Small Cell Lung Cancer Chest, September 1, 2005; 128(3): 1545 - 1550. [Abstract] [Full Text] [PDF]

				D. Lardinois, H. Suter, H. Hakki, V. Rousson, D. Betticher, and H.-B. Ris Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small Cell Lung Cancer Ann. Thorac. Surg., July 1, 2005; 80(1): 268 - 275. [Abstract] [Full Text] [PDF]

				C. Doddoli, A. Aragon, F. Barlesi, B. Chetaille, S. Robitail, R. Giudicelli, P. Fuentes, and P. Thomas Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer? Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 680 - 685. [Abstract] [Full Text] [PDF]

				A. Lopez-Encuentra, R. Garcia-Lujan, J. Jose Rivas, J. Rodriguez-Rodriguez, J. Torres-Lanza, G. Varela-Simo, and Bronchogenic Carcinoma Cooperative Group of the Sp Comparison Between Clinical and Pathologic Staging in 2,994 Cases of Lung Cancer Ann. Thorac. Surg., March 1, 2005; 79(3): 974 - 979. [Abstract] [Full Text] [PDF]

				O. Altundag, K. Altundag, M. Gunduz, F. Graziano, Y. Ichinose, and N. Hamajima Uracil-Tegafur in Early-Stage Lung Cancer N. Engl. J. Med., August 12, 2004; 351(7): 713 - 714. [Full Text] [PDF]

				J. Barnard, J. Dunning, G. Musleh, and N. Odom Is there a role for the use of radical lymph node dissection in the surgical management of resectable non-small cell lung cancer? Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 294 - 299. [Abstract] [Full Text] [PDF]

				G. A. Lawrence and J. Crawford Benefits of Locoregional Treatment J. Clin. Oncol., December 15, 2003; 21(24): 4660 - 4661. [Full Text] [PDF]

				E. R. Sigurdson Lymph Node Dissection: Is It Diagnostic or Therapeutic? J. Clin. Oncol., March 15, 2003; 21(6): 965 - 967. [Full Text] [PDF]